IMPROVED DOWNREGULATION OF HISTONE CYTOTOXICITY BY COMPLEX OF NEGATIVELY CHARGED POLYSACCHARIDE AND PROTEASE
Described herein is a complex of a negatively charged polysaccharide and a protein having serine protease activity. The negatively charged polypeptide can for example be heparin or non-anticoagulant heparin. The serine protease can for example be an elastase or activated protein C. The complex can be used in the treatment, prevention or amelioration of an immunothrombosis related disease or disorder..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 04. Jan. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
NICOLAES GERARDUS ANNA FRANCISCUS [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-01-04, Last update posted on www.tib.eu: 2024-01-24, Last updated: 2024-02-02 |
|---|
| Patentnummer: |
WO2024003418 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA019028245 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA019028245 | ||
| 003 | DE-627 | ||
| 005 | 20240202090733.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240126s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA019028245 | ||
| 035 | |a (EPA)WO2024003418 | ||
| 035 | |a (EPA)82492389 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a NICOLAES GERARDUS ANNA FRANCISCUS |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a IMPROVED DOWNREGULATION OF HISTONE CYTOTOXICITY BY COMPLEX OF NEGATIVELY CHARGED POLYSACCHARIDE AND PROTEASE |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-01-04, Last update posted on www.tib.eu: 2024-01-24, Last updated: 2024-02-02 | ||
| 520 | |a Described herein is a complex of a negatively charged polysaccharide and a protein having serine protease activity. The negatively charged polypeptide can for example be heparin or non-anticoagulant heparin. The serine protease can for example be an elastase or activated protein C. The complex can be used in the treatment, prevention or amelioration of an immunothrombosis related disease or disorder. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a REUTELINGSPERGER CHRISTIAAN PETER MARIA |4 aut | |
| 700 | 0 | |a HUCKRIEDE JORAM BERND |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 04. Jan. |
| 773 | 1 | 8 | |g year:2024 |g day:04 |g month:01 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/82492389/publication/WO2024003418A1?q=WO2024003418 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2024 |b 04 |c 01 |
| 951 | |a AR | ||
| 952 | |j 2024 |b 04 |c 01 | ||